Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119


3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.

Vivar OI, Lin CL, Firestone GL, Bjeldanes LF.

Biochem Pharmacol. 2009 Sep 1;78(5):469-76. doi: 10.1016/j.bcp.2009.05.008. Epub 2009 May 9.


Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.

Chinnakannu K, Chen D, Li Y, Wang Z, Dou QP, Reddy GP, Sarkar FH.

J Cell Physiol. 2009 Apr;219(1):94-9. doi: 10.1002/jcp.21650.


p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells.

Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani RA, Agarwal R.

Mol Cancer Ther. 2007 Oct;6(10):2696-707.


A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.

Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R.

Cancer Res. 2005 Feb 1;65(3):1035-44.


Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.

Wang Z, Lee HJ, Chai Y, Hu H, Wang L, Zhang Y, Jiang C, Lü J.

Curr Cancer Drug Targets. 2010 May;10(3):307-18.


BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.

Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL.

Cancer Biol Ther. 2010 Aug 15;10(4):397-405. Epub 2010 Aug 20.


3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.

Jin Y, Zou X, Feng X.

Anticancer Drugs. 2010 Oct;21(9):814-22. doi: 10.1097/CAD.0b013e32833e53ea. Retraction in: Anticancer Drugs. 2011 Mar;22(3):303.


Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.

Won SH, Lee HJ, Jeong SJ, Lü J, Kim SH.

Phytother Res. 2012 May;26(5):669-74. doi: 10.1002/ptr.3616. Epub 2011 Oct 13.


Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.

Hsu JC, Zhang J, Dev A, Wing A, Bjeldanes LF, Firestone GL.

Carcinogenesis. 2005 Nov;26(11):1896-904. Epub 2005 Jun 15.


Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein.

Hsu JC, Dev A, Wing A, Brew CT, Bjeldanes LF, Firestone GL.

Biochem Pharmacol. 2006 Dec 15;72(12):1714-23. Epub 2006 Sep 12.


Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.

Zhang Y, Kim KH, Zhang W, Guo Y, Kim SH, Lü J.

Int J Cancer. 2012 Jan 1;130(1):200-12. doi: 10.1002/ijc.25993. Epub 2011 May 9.


Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.

Oncogene. 2001 May 24;20(23):2927-36.


Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.

Li H, Qi Y, Li C, Braseth LN, Gao Y, Shabashvili AE, Katovich MJ, Sumners C.

Mol Cancer Ther. 2009 Dec;8(12):3255-65. doi: 10.1158/1535-7163.MCT-09-0237. Epub .

Items per page

Supplemental Content

Write to the Help Desk